Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus

A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea

NCT04980014 ·Status: COMPLETED

Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin

NCT06571591 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

NCT03910361 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects

NCT06688123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

NCT06007014 ·Status: NOT_YET_RECRUITING ·Phase: NA

Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients

NCT02314637 ·Status: COMPLETED ·Phase: PHASE3

Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients

NCT00461617 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus

NCT02916706 ·Status: COMPLETED ·Phase: PHASE3

An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010

NCT01294553 ·Status: COMPLETED

Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes

NCT01301833 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

NCT02946541 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

NCT05028140 ·Status: RECRUITING ·Phase: PHASE3

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

NCT00494312 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes

NCT00628212 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

NCT03848793 ·Status: COMPLETED ·Phase: PHASE2

Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus

NCT01798238 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

NCT00402909 ·Status: COMPLETED ·Phase: PHASE4

A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

NCT04980040 ·Status: COMPLETED

A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy

NCT06649162 ·Status: RECRUITING

Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

NCT02188186 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus

NCT02924064 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

NCT02946632 ·Status: UNKNOWN ·Phase: PHASE3

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

NCT02649465 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

NCT07093476 ·Status: RECRUITING ·Phase: PHASE3

Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus

NCT00458016 ·Status: COMPLETED ·Phase: PHASE2